08.00 - 09.30

Oral Posters

Chairs: Constant Jehaes (Belgium), Sergii Podpriatov (Ukraine)

  • OP25 Risk factors predicting intra-abdominal desmoid occurrence in familial adenomatous polyposis - Ashish Sinha (UK)
  • OP26 Gadofosveset-enhanced MRI for nodal staging in rectal cancer: predictive criteria - Geerard Beets (Netherlands)
  • OP27 Does the number of lymph nodes harvested at pathology in rectal cancer depend on the surgeon and pathologist only? - Geerard Beets (Netherlands)
  • OP28 Emergency colorectal surgery in the elderly: do patients benefit? - Ravikrishna Mamidanna (UK)
  • OP29 Insights into fast-track in colorectal surgery: a plea for tailored program - Remue Christophe (Belgium)
  • OP30 Small bowel magnetic resonance imaging without contrast or gastric intubation - Gemma Conn (UK)
  • OP31 The effects of anti-muscarinic agents on rectal compliance in patients with supraconal Spinal Cord Injury - Giuseppe Preziosi (UK)
  • OP32 Female fertility after pouch surgery - Sanne Bartels (Netherlands)
  • OP33 A Systematic Review of the Safety and Efficacy of Injectable Bulking Agents for the Treatment of Faecal Incontinence - Zeiad Hussain (UK)
  • OP34 Techniques and Results for the Treatment of Anovaginal Fistulas in a Specialized Colorectal Unit - Marcos Adrianzén (Spain)
  • OP35 Factors influencing recurrence after surgical treatment of ano-genital warts - Massimiliano Mistrangelo (Italy)
  • OP36 Side-to-side stapled versus end-to-end handswen anastomoses for laparoscopic right colectomy: preliminary results of a randomised controlled trial - Mariano Laporte (Argentina)
  • OP37 A randomized controlled study between radiowave fistulotomy and conventional fistulotomy in low anal fistula - Pravin Gupta (India)
  • OP38 Learning curve for endorectal ultrasonography in rectal tumors - Joost Nonner (Netherlands)
  • OP39 An open label study to examine the effect of coated Nifedipine suppositories on anal pressure in healthy subjects - Michael Shapiro (Israel)
  • OP40 Pelvic Organ Prolapse associated with Rectal Prolapse in Women: a comparison of dynamic CT and fluoroscopic cystocolpoproctography - Yasumi Araki (Japan)
  • OP41 Is stapled haemorrhoidopexy cost-effective and even cost-saving in UK clinical practice? - David Jayne (UK)
  • OP42 The hydrojet-supported, submucosial endoscopicmicrosurgical excision of giant rectum-adenoma – follow-up data - Joerg Baral (Germany)

Oral Posters (parallel auditorium)

Chairs: Milan Breberina (Serbia), Michael Gerhards (The Netherlands)

  • OP43 Preoperative chemo-radiotherapy in t3 rectal tumors: is it always necessary? Preoperative classification with endorectal ultrasound is a prognostic factor - Matteo Frasson (Spain)
  • OP44 Decreased morbidity after laparoscopic rectal excision with adapted tools - Christophe Laurent (France)
  • OP45 Predicting survival after resection of pulmonary metastases from colorectal cancer: a history of previous liver metastases matters - Pascal Gervaz (Switzerland)
  • OP46 Chemoradiotherapy versus radiotherapy alone for early (T1-T2N0) squamous cell carcinoma of the anus - Pascal Gervaz (Switzerland)
  • OP47 Screening HNPCC syndrome in colorectal cancer: are we doing enough? - Jeremie Lefevre (France)
  • OP48 Intraoperative pelvic hyperthermic chemotherapy is method of treatment the locally advanced cancer of rectum - Mikhail Alekseev (Russian Federation)
  • OP49 Tumor Budding in Submucosa: an Optimal Predictive Factor for Clinical Outcome in Colorectal Cancer - Hiroshi Uchida (Japan)
  • OP50 Total pelvic exenteration for primary advanced rectal cancer and locally recurrent rectal cancer  - Mette Bak Nielsen (Denmark)
  • OP51 Modulation of preoperative chemoradiation can reduce the risk of abdomino-perineal resection in low rectal cancer patients - Emanuele Urso (Italy)
  • OP52 Perineal colostomy offers better quality of life than iliac colostomy after abdominoperineal resection - Sylvain Kirzin (France)
  • OP53 Is it true that screen detected colorectal cancer (CRC) patients are asymptomatic? Results from North Staffordshire Bowel Cancer Screening Unit - Bala Piramanayagam (UK)
  • OP54 Long term results of local excision for rectal cancer with complete rectal wall response after neoadjuvant therapy - Nidal Issa (Israel)
  • OP55 Anal cancer in HIV patients: a 20-year experience - Maryam Alfa-Wali (UK)
  • OP56 Transanal endoscopic microsurgery combined with endoscopic posterior mesorectum excision in the treatment of patients with t1 rectal cancer : own results - Piotr Walega (Poloand)
  • OP57 Serum amyloid protein A combined with multi-slice spiral computed tomography image improve identification of metastatic lymph node in colorectal cancer - Xiaodong Wang (China)
  • OP58 Adherence with the ERAS-protocol and outcomes after colo-rectal cancer surgery - Ulf Gustafsson (Sweden)
  • OP59 Surgical intervention after palliative placement self-expandable metal stent placement for malignant colonic obstruction: How often and why? - Ji Sun Kim (Republic of Korea)
  • OP60 18F-FDG PET/CT for preoperative staging in patients with rectal cancer - Seda Lacin (Turkey)
09.30 - 10.30

Symposium: Modern Treatment of Acute Colitis

Chairs: Fabrizio Michelassi (USA); Tom Oresland (Norway)

  • Definition and scoring - Franck Carbonnel (France)
  • Have biologics changed management? - Gunnar Jarnerot (Sweden)
  • When and how to intervene surgically? - Willem Bemelman (The Netherlands)
10:30 - 11:00


11:00 - 11:30

Keynote Lecture: Anastomotic leaks, bleeding and other post-operative misery

Bruce Wolff (USA)

Chair: P. Ronan O'Connell (Ireland)

Supported by a grant from the British Journal of Surgery

11:30 - 12:30

Symposium: Peritoneal Carcinomatosis

Chairs: Brendan Moran (UK), Lars Påhlman (Sweden)

  • Management of bowel obstruction - Carla Ripamonti (Italy)
  • Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - Vic Verwaal (The Netherlands)
  • Perioperative morbidity and quality of life - Pompiliu Piso (Germany)
12:30 - 12:35

Best Abstract Awards

Giovanni Romano (Italy)

12:35 - 13:30

ESCP Annual General Meeting